Showing results (91-100 of 116) with videos related to

Sort By:
Pageof 12
European Journal of Nuclear Medicine|June 18, 1998
In vivo evaluation of a lead-labeled monoclonal antibody using the DOTA ligandD E Milenic, M Roselli, M W Brechbiel, et al.
Medical Oncology (Northwood, London, England)|December 6, 2013
A prospective observational study to evaluate G-CSF usage in patients with solid tumors receiving myelosuppressive chemotherapy in Italian clinical oncology practiceS Barni, V Lorusso, M Giordano, et al.
The International Journal of Biological Markers|April 18, 2003
Prognostic value of serum and tumor tissue CA 72-4 content in gastric cancerS Aloe, R D'Alessandro, A Spila, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 16, 2013
TNF-α gene promoter polymorphisms and risk of venous thromboembolism in gastrointestinal cancer patients undergoing chemotherapyM Roselli, P Ferroni, C Rolfo, et al.
Anticancer Research|June 12, 1999
Evaluation of the CA 242 tumor antigen as a potential serum marker for colorectal cancerA Spila, P Ferroni, M Cosimelli, et al.
Tumori|October 9, 2002
Minimal sentinel node procedure for staging early breast cancerS Mariotti, O Buonomo, F Guadagni, et al.
Neurology|December 22, 1999
Prevalence of epilepsy in rural Bolivia: a door-to-door surveyA Nicoletti, A Reggio, A Bartoloni, et al.
Anticancer Research|July 1, 1996
TAG-72 expression and its role in the biological evaluation of human colorectal cancerF Guadagni, M Roselli, M Cosimelli, et al.
Neurology|April 24, 2002
Epilepsy, cysticercosis, and toxocariasis: a population-based case-control study in rural BoliviaA Nicoletti, A Bartoloni, A Reggio, et al.
International Journal of Cancer|November 5, 1997
Quantitative analysis of CEA expression in colorectal adenocarcinoma and serum: lack of correlationF Guadagni, M Roselli, M Cosimelli, et al.
Pageof 12